Facebook wants pharma money

Image for post
Image for post

KEY TAKEAWAY: Facebook wants pharma money and they want it for everything from advertising new drugs to clinical trials but obstacles still remain.

CNBC recently said “some drug companies have been reluctant to use Facebook due to concerns that patients will share sensitive information like medical side effects and adverse events”. However, patients will tell you, if you listen, that they are afraid to post or follow health conditions on social media due to retargeting.

Two months ago I was doing some research for a client on MS and social media. For more than two days I received “suggested posts/groups’ to follow/read. When I had my client do the same thing she became incensed telling me “this is last things MS patients want”.

Can it be done?

The key challenge is being able to have a conversation without having to have every word cleared by your M L R team. When it comes to adverse events pharma can monitor social media and give patients who report an adverse event an eMail address or URL to report their event. The idea that pharma would ask someone on social media for their name and address is beyond comprehension.

The Facebook problem…

Anyone can deploy Facebook ads. They are affordable and easy. That’s one reason that Facebook has grown so quickly, taking in $27.6 billion in revenue in 2016, virtually all of it from advertisers, by serving up the attention of two billion Facebook users across the globe. A core principle in political advertising is transparency. None of that transparency matters to Facebook. Ads on the site meant for, say, 20- to 30-year-old home-owning Latino men in Northern Virginia would not be viewed by anyone else, and would run only briefly before vanishing. The potential for abuse is vast.

Can a disreputable supplement company, for example, post an ad that looks like a pharma ad? You betcha and who do you think will take the fall?

We tested a facebook post targeted at depression suffers that had good information about getting help for depression and it did very well. The key was that the post was informational, not a sales pitch. If someone wanted more information it took them to an unbranded site that was rich in content. When we rad the post traffic spiked with a majority of users going to the unbranded site and onto the branded site. However, when we changed the post to “a sales pitch” it did very poorly.

The lessons are there if pharma wants to really learn.

Originally published at worldofdtcmarketing.com on September 9, 2017.

Written by

Marketing contrarian with over 15 years of developing leading edge and award winning digital marketing initiatives.

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store